University Senate approves biology major, delays vote on botany, zoology merger

The Miami University Senate voted Monday to approve a new biology major.

The decision came after the Senate opted to table a vote on merging the botany and zoology departments until the Senates next meeting in two weeks.

Regardless of the outcome of the botany-zoology merger, James Hickey, interim chair of the botany department, said approving the biology major is a step in the right direction.

This is something that we all feel we need to move forward on, Hickey said. Its important for recruitment, and we feel that its a good synthesis of where we need to be.

According to Doug Meikle, chair of the zoology department, the creation of the biology major will appeal to prospective high school students looking specifically for biology as a course of study.

Thats the word that high school students understand best, Meikle said. A lot of this has to do with recruitment.

The decision to merge the botany and zoology departments, which was tabled, has several justifications, according to Phyllis Callahan, dean of the college of arts and sciences. The proposed merger would also enhance recruitment, as well as achieve efficiencies in staffing and course offerings and enhance collaboration among faculty, Callahan said.

According to Callahan, there are several benefits to merging the two departments, including saving staff positions, saving a department chair stipend and supplemental salary, as well as achieving curricular efficiency and reducing redundancies in the departments.

The Senate also heard special reports from the benefits committee about the 2012 benefits activities as well as employee benefit changes to expect in 2013.

Additionally, the Senate heard a special report from Deedie Dowdle, associate vice president of university communications and marketing, on the Miami logo, branding and domain name. Dowdle updated the Senate on the Miami website redesign, the domain name and logo change, a style guide for identity standards and overarching university branding.

Excerpt from:
University Senate approves biology major, delays vote on botany, zoology merger

Valley Center students hope to raise enough money to compete in space education program

The students in Jeff Tracys biology class last week were making paper helicopters and adjusting them to see how far and accurately they could fly.

In coming months, they could be developing experiments that could travel through space to the International Space Station.

This is just an amazing opportunity for our school and our students, said Tracy, a science teacher at Valley Center High School. This is real science, not just content in the classroom.

Valley Center is one of 24 communities to be accepted as a candidate for Mission 3 of the Student Spaceflight Experiment Program. The program, part of the National Center for Earth and Space Science Education, is designed to give students hands-on experience designing, building, testing and conducting experiments for space flight.

The schools first hurdle is financial: It needs to secure $20,000 in donations or pledges by Wednesday to participate.

Its a lot of money, but we are optimistic, said Jamie Lewis, principal at Valley Center High School.

Weve had a good response so far. With all the aerospace companies and other businesses here locally, were hoping the community really embraces this opportunity for our students.

If the school meets the Wednesday deadline and is approved to participate, students enrolled in mid- to upper-level science classes including biology, chemistry, physics and statistics would work in teams to brainstorm experiments that could be tested in low gravity.

A review board would narrow the experiments to three finalists, and those would advance to the next round of the Student Spaceflight Experiment Program. The program then would select one Valley Center project to fly in low Earth orbit and then on to the International Space Station.

The program provides each participating community a research mini-laboratory capable of supporting one microgravity experiment and launch services to fly the mini-lab to the space station in early April 2013.

See the original post here:
Valley Center students hope to raise enough money to compete in space education program

Biology in pictures: the science that could save the world

Another of the images, taken by Wong Chi Keung, shows fields of seaweed being grown in Fujian, china, where it is being harvested to produce biofuels.

Oil produced by the seaweed is collected and refined so it can be used in lawn mowers and cars.

A bumblebee collecting pollen from a wild flower, taken by William Richardson in Fulham, London, illustrates the threat posed to pollinators.

A graduate student overseeing the growth of algae in test tubes at the University of Tennessee in Knoxville, USA, also shows the striking green the blooms can create.

Taken by Mohammad Moniruzzaman, the project it illustrates is aimed at better understanding the organisms that make up these important ocean blooms, which are major contributors to the world's oxygen supply.

The winners are due to be announced in October at Charles Darwin House in London. The entire shortlist alongside those from the young photographers category will be put on display as part of Biology Week.

Read the original post:
Biology in pictures: the science that could save the world

New book reviews the biology of synapses

Public release date: 6-Sep-2012 [ | E-mail | Share ]

Contact: Elizabeth Powers powerse@cshl.edu 516-422-4101 Cold Spring Harbor Laboratory

Synapses are bulbous structures where two neurons communicate. Neurotransmitter molecules released from the presynaptic terminal of one neuron diffuse to the postsynaptic terminal on the other, binding to receptors that lead to propagation or modulation of the signal.

Written and edited by experts in the field, The Synapse from Cold Spring Harbor Laboratory Press examines the highly complex structures of the pre- and postsynaptic regions, as well as the trafficking mechanisms that transport vesicles containing neurotransmitters. The contributors discuss how long-term potentiation (LTP) and long-term depression (LTD) of synaptic transmission form the basis of learning and memory. The roles of calcium signaling in regulating synaptic and cell function and techniques to study such signaling events are also covered.

This volume also includes discussions of synaptic dysfunction in disorders such as autism and Alzheimer's disease. It is an indispensable reference for neurobiologists, cell and developmental biologists, and anyone wishing to understand how the basic building blocks of the brain are put together and communicate.

###

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

See the original post:
New book reviews the biology of synapses

Iran hosts stem cell biology congress

Iran has held the 8th Congress on Stem Cell Biology and Technology, hosting scientists from nine countries in the capital city of Tehran, Press TV reports.

A group of fourteen scientists have participated in the event to discuss the importance of stem cell research and its ability to prevent genetic diseases.

Irans Royan Institute for Reproductive Biomedicine, Stem Cell Biology, and Technology is the countrys leading biomedical research center involved in stem cell technology and regenerative medicine.

Royan Institute researchers have used stem cell therapy to treat patients with cardiac arrest, chronic lower extremities ulcers, liver cirrhosis, and vitiligo.

They have also succeeded in cloning various farm animals, including a lamb named 'Royana', a goat named 'Hanna' and two calves called 'Bonyana' and 'Tamina'.

I think Iran has [made] quite a number of scientific contributions to both stem cell research and reproductive biomedicine and its a really good opportunity to be here and learn more about them, said Prof. Paul Tesar of the Case Western Reserve University, US.

Iran has also taken great strides in other scientific sectors including biotechnology, medical science and aerospace research.

TE/SS

See more here:
Iran hosts stem cell biology congress

Research and Markets: Essential Zebrafish Methods: Cell and Developmental Biology – Reliable Lab Solutions

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/kwt8xq/essential_zebrafis) has announced the addition of Elsevier Science and Technology's new report "Essential Zebrafish Methods: Cell and Developmental Biology. Reliable Lab Solutions" to their offering.

Due to its prolific reproduction and the external development of the transparent embryo, the zebrafish is the prime model for genetic and developmental studies, as well as research in genomics. While genetically distant from humans, nonetheless the vertebrate zebrafish has comparable organs and tissues which make it the model organism for study of vertebrate development. This book will provide overview of commonly used methods and a comprehensive collection of protocols describing the most powerful techniques. The methods and techniques in this volume were chosen by the editors of Methods in Cell Biology, whose goal was to provide fail-safe methods, tips, and "tricks of the trade? to experienced researchers and more junior members in the lab.

Key Topics Covered:

For more information visit http://www.researchandmarkets.com/research/kwt8xq/essential_zebrafis

Source: Elsevier Science and Technology

See the rest here:
Research and Markets: Essential Zebrafish Methods: Cell and Developmental Biology - Reliable Lab Solutions

Danforth Plant Science Center hosts 14th Annual Fall Symposium

Public release date: 4-Sep-2012 [ | E-mail | Share ]

Contact: Melanie Bernds mbernds@danforthcenter.org 314-587-1647 Donald Danforth Plant Science Center

ST. LOUIS, MO, September 4, 2012 The Donald Danforth Plant Science Center will be hosting its 14th annual Fall Symposium from Wednesday, September 26th Friday, September 28th, 2012. This year's symposium will feature lectures by influential experts from across the world who will present on a wide range of topics on cutting-edge science. This year's theme will focus on synthetic and systems level explorations in biology that are establishing fundamental emergent properties of complex biological systems.

"The annual symposium is an opportunity for a diverse group of scientists from private research, industry and universities to interact and learn from state-of-the-art talks on focused topics within biology," said Doug Allen, USDA Research Scientist, Assistant Member, Donald Danforth Plant Science Center who is organizing this year's event. "This is another example of how the Center works to enhance science in the St. Louis region."

Systems biology uses quantitative experimental approaches and computational modeling to understand how a multitude of components work together as a system to enable living systems to function. In addition, synthetic biology extends this understanding by redesigning and manipulating the capabilities of a biological system to achieve new and different goals. The Center's symposium will explore how systems and synthetic biology are complementary and facilitate the engineering of living systems with new functions and properties.

"The three day symposium breaks into four concentrated sessions with multiple speakers discussing gene networks, rewiring, metabolism, and genomes evolution" said Dr. Todd Mockler, the Geraldine and Robert Virgil Distinguished Investigator at the Danforth Center and Symposium organizer. "The themed sessions give attendees a variety of comprehensive lectures relating to synthetic and systems biology."

Registration will remain open until September 19th, 2012. The registration fee includes access to all sessions, social events, breaks and meals as indicated in the program. For a list of the esteemed speakers and topics please visit http://www.danforthcenter.org/fall_symposium/speakers.asp.

The registration fee for post-doctoral fellows, technicians or equivalent is reduced. Graduate students are welcome to participate for free. To register, please visit http://www.danforthcenter.org/symposium_registration/.

###

Sponsors

Go here to see the original:
Danforth Plant Science Center hosts 14th Annual Fall Symposium

Jonathan DiVincenzo Joins Enzymatics as President and Chief Executive Officer

BEVERLY, Mass.--(BUSINESS WIRE)--

Enzymatics, Inc., a rapidly growing provider of molecular biology reagents, today announced the appointment of Jonathan DiVincenzo as President and Chief Executive Officer. Mr. DiVincenzo brings more than 20 years of industry experience to the role having previously served as Corporate Officer of Millipore Corporation andPresident of its Bioscience Division. Mr. DiVincenzo joins Enzymatics to continue the growth fueled by the immense scientific skill set, drive and ambition of the Companys workforce.

Jon is a visionary leader with a strong track record of building global businesses serving the life science industry," said Ian Ratcliffe, Chairman of Enzymatics Board of Directors. "His experience and capabilities in bringing new technologies to global markets make him uniquely qualified to lead Enzymatics through its next wave of growth."

Enzymatics co-founders Stephen Picone and Christopher Benoit commented, Enzymatics has evolved into a thriving business from a startup in 2007, growing to approximately 100 employees in just five years. We welcome Jon to the Enzymatics family, and with his extensive commercial and strategic experience, we will continue to build Enzymatics as the leading global supplier of high quality reagents and services to the rapidly expanding molecular genetics industry. Stephen Picone and Chris Benoit are remaining at the Company in active roles under the new titles, Chief Strategy Officer and Chief Commercial Officer, respectively.

Mr. DiVincenzo has held several key leadership positions during his 18-year tenure at Millipore Corporation (now Merck Millipore).As the President of the Companys Bioscience Division, Jon led 1200 employees and grew the division to over $600 million of revenues. Prior to that he served as Vice President of Global Sales and Service and as Vice President of Marketing and R&D. For several years, he also held senior marketing and product management positions within Millipores Lab Water business (which later became part of the Bioscience Division) in Paris. Before Millipore, Jon worked for Orion Research (now part of ThermoFisher Scientific) as Product Manager and Technical Support Engineer and for General Electric Corporation in thermodynamics engineering. Jon holds a Bachelor of Science degree in Mechanical Engineering from Northeastern University in Boston. He is a member of the Northeasterns College of Engineering Advisory Board and Board of Directors of the Analytical and Life Science Systems Association (ALSSA).

About Enzymatics

Enzymatics is a leading provider of molecular biology reagents and manufacturing services that delivers unrivaled quality, consistency, and value to the commercial genomic sciences community. The company manufactures in the USA under ISO 13485 certification, is focused on building long-term partnerships, and leverages internal and external innovation to commercialize breakthrough technologies. http://www.enzymatics.com

Photos/MultimediaGallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50394385&lang=en

MULTIMEDIA AVAILABLE:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50394385&lang=en

See the article here:
Jonathan DiVincenzo Joins Enzymatics as President and Chief Executive Officer

GLOBAL BIOENERGIES nominated as one of the five most innovative European biotech SMEs by EuropaBio

EVRY, France--(BUSINESS WIRE)--

Global Bioenergies (ALGBE.PA), an industrial biology company developing sustainable routes to light olefins, has been nominated as one of the five most innovative European biotech SMEs by EuropaBio, representing more than 1800 European companies.

EuropaBio, the principal organization to represent more than 1800 of Europes biotechnology companies, has communicated the choice of its expert panel for the Most Innovative EU Biotech SME Award 2012 in the press release which can be found under http://www.europabio.org/sme/press/who-are-europes-5-most-innovative-biotech-smes.

The award ceremony will be held on September 19th in the European Parliament by Commission Vice President Antonio Tajani, Commissioner for Industry & Entrepreneurship.

Marc Delcourt, co-founder and CEO of Global Bioenergies, comments: We are very honored by the choice of the expert panel of this prestigious biotechnology award, in particular because it was open to all European biotechnology companies acting in fields as diverse as pharmaceuticals, diagnostics, plant science, environment and industrial biology. We would like to thank EuropaBio for their recognition of our unique synthetic biology-based approach to convert renewable resources into light olefins, the core molecules of the petrochemical industry, and more generally for their support to the emerging industrial biology community.

About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the yield of its process and prepares the phase dedicated to pilot testing. The company is also looking to replicate this success with other members of the gaseous olefins family (propylene, ethylene, linear butylenes, butadiene), key molecules at the heart of petrochemical industry. Global Bioenergies is listed on NYSE Alternext Paris (FR0011052257 ALGBE).

Should you like to be kept informed, subscribe to our news feed on http://www.global-bioenergies.com

See the original post here:
GLOBAL BIOENERGIES nominated as one of the five most innovative European biotech SMEs by EuropaBio

The eyes have it: Men do see things differently to women

Public release date: 3-Sep-2012 [ | E-mail | Share ]

Contact: Dr. Hilary Glover hilary.glover@biomedcentral.com 44-020-319-22370 BioMed Central

The way that the visual centers of men and women's brains works is different, finds new research published in BioMed Central's open access journal Biology of Sex Differences. Men have greater sensitivity to fine detail and rapidly moving stimuli, but women are better at discriminating between colors.

In the brain there are high concentrations of male sex hormone (androgen) receptors throughout cerebral cortex, especially in the visual cortex which is responsible for processing images. Androgens are also responsible for controlling the development of neurons in the visual cortex during embryogenesis, meaning that males have 25% more of these neurons than females.

Researchers from Brooklyn and Hunter Colleges of the City University of New York compared the vision of men and women aged over 16 from both college and high school, including students and staff. All volunteers were required to have normal color vision and 20/20 sight (or 20/20 when corrected by glasses or contact lenses).

When the volunteers were required to describe colors shown to them across the visual spectrum it became obvious that the color vision of men was shifted, and that they required a slightly longer wavelength to experience the same hue as the women. The males also had a broader range in the center of the spectrum where they were less able to discriminate between colors.

An image of light and dark bars was used to measure contrast-sensitivity functions (CSF) of vision; the bars were either horizontal or vertical and volunteers had to choose which one they saw. In each image, when the light and dark bars were alternated the image appeared to flicker.

By varying how rapidly the bars alternated or how close together they were, the team found that at moderate rates of image change, observers lost sensitivity for close together bars, and gained sensitivity when the bars were farther apart. However when the image change was faster both sexes were less able to resolve the images over all bar widths. Overall the men were better able to resolve more rapidly changing images that were closer together than the women.

Prof Israel Abramov, who led this study commented, "As with other senses, such as hearing and the olfactory system, there are marked sex differences in vision between men and women. The elements of vision we measured are determined by inputs from specific sets of thalamic neurons into the primary visual cortex. We suggest that, since these neurons are guided by the cortex during embryogenesis, that testosterone plays a major role, somehow leading to different connectivity between males and females. The evolutionary driving force between these differences is less clear."

###

See more here:
The eyes have it: Men do see things differently to women

GSW, Chehaw collaborate in conservation biology

Albany Chehaw Parks Education and Animal Care Department and Georgia Southwestern State University (GSW) Biology Department are to begin a new partnership in conservation biology. For the first time during fall semester 2012, the University and the Zoo will collaborate in teaching a class in Zoo Animal Care and Maintenance.

It has always been a dream of mine to see Chehaw used to engage students as a learning institution, said Doug Porter, executive director for Chehaw. This new and exciting partnership will not only be beneficial to the Park and the University but to the greater community of Southwest Georgia.

The class will be a hands-on practice-oriented course in which more time will be spent working at the Zoo than sitting in the classroom. The goals of the course are to introduce students with a passion for animal husbandry and conservation to a career in zoo keeping. The course will cover the basics in zoo keeping, including, animal handling techniques, management, nutrition, breeding, behavior enrichment, exhibit design, zoo administration and public education of the major animal groups.

I am looking forward to getting this program off of the ground, shared Ian Brown, Ph.D., associate professor of biology at GSW. The chance to have our students working in this field as undergraduates will give them the experience that they will need when applying for future jobs in conservation.

The relationship between Chehaw Park and GSW has slowly gained momentum over the past eight years. As early as 2004, biology students began visiting the zoo to conduct behavioral observation laboratories on various animals such as the colobus monkey, flamingos, lemurs, meerkats and cheetahs. In recent years the zoo has used these student assignments as supporting material in grant applications. To date, three GSW biology majors have been hired as summer program instructors and another three have volunteered as zoo keeper assistants.

Zoo Animal Care and Maintenance students will spend their classroom time studying the theoretical aspects of the husbandry and welfare of non-domesticated animals in captivity and the logistics of zoological and conservation park operation. The overall focus in the classroom will be on the role that modern zoos must play in habitat and species conservation.

At Chehaw, the students will work alongside zoo professionals to learn the practical details of this important field. They also will be spending time with some of the Zoos leadership team, the Zoo director, the Zoo curator and Education coordinator to gain valuable insight into the inner workings of an AZA (Association of Zoos and Aquariums) -accredited Zoo.

This first class is being made possible through the willingness of university faculty and zoo personnel to take on additional workloads. In the future it is hoped that this initial class will grow into an entire zoo technology program with an emphasis in threatened species conservation.

The course instructors realize that modern Zoological and Conservation Parks and Aquariums utilize cutting edge technology to care for and breed many hundreds of animal species. Therefore most parks now require that their staff hold the minimum of a two-year and preferably a four-year degree in biology, animal husbandry or related field.

These new demands have opened up unique university-zoo collaboration opportunities to provide the requisite qualified zoo animal care personnel. Furthermore, in the near future a greater demand for zoos and aquariums is predicted, as their roles in animal conservation become increasingly more valuable.

Original post:
GSW, Chehaw collaborate in conservation biology

Bioinformatics: The Early Years

Bioinformatics historians take note: PLOS Computational Biology has published a comprehensive backgrounder on the field's biggest annual meeting the Intelligent Systems for Molecular Biology conference, which celebrated its 20th anniversary this year.

Larry Hunter, who spearheaded the first ISMB in 1993, shares details on how the meeting grew out of a small group of artificial intelligence researchers with an interest in molecular biology. Other early organizers like Richard Lathrop, Russ Altman, Peter Karp, David Searls, and Alfonso Valencia weigh in on how the meeting and the field in general has changed during the past 20 years.

The first meeting was done "on a shoestring," Hunter says. "The program covers one 8.5 x 11 sheet, both sides, which I folded into three and made a nice, neat schedule, complete with the poster session. I kind of remember, now, putting that together on my early Mac. We did things pretty much on the cheap."

At the time, Lathrop says, "nobody had even broached the idea of sequencing the human genome. It was just too gargantuan and mammoth a task, and was considered almost heresy in its early days."

And despite the huge amount of progress during the last 20 years, there's still plenty of room for better bioinformatics tools. "We can sequence somebody's genome, and we've learned virtually nothing with any reasonable amount of certainty," Karp says. "I sure hope that in 10 or 20 years, we can do a lot more with a personal genome predict not just that they're five percent more likely to get some disease, but that they're 90 percent more likely to get one or more diseases. And the treatment that will help that individual."

For more reflections on ISMB's first 20 years, check out a recent interview with Hunter at our sister publication BioInform.

See original here:
Bioinformatics: The Early Years

Cancer 'turns off' important immune cells, complicating experimental vaccine therapies

Public release date: 30-Aug-2012 [ | E-mail | Share ]

Contact: Cody Mooneyhan cmooneyhan@faseb.org 301-634-7104 Federation of American Societies for Experimental Biology

Bethesda, MDA research report published in the September 2012 issue of the Journal of Leukocyte Biology offers a possible explanation of why some cancer vaccines are not as effective as hoped, while at the same time identifies a new therapeutic strategy for treating autoimmune problems. In the report, scientists suggest that cancer, even in the very early stages, produces a negative immune response from dendritic cells, which prevent lymphocytes from working against the disease. Although problematic for cancer treatment, these flawed dendritic cells could be valuable therapeutic tools for preventing the immune system from attacking what it should not, as is the case with autoimmune disorders and organ transplants.

"Immunotherapy of cancer has been an elusive research target that, though promising, never seems to 'get there,'" said Jos Alexandre M. Barbuto, Ph.D., from the Laboratory of Tumor Immunology, Department of Immunology, Institute of Biomedical Sciences at the University of So Paulo, in So Paulo, Brazil. "This study helps us to better understand the mechanisms by which tumors avoid immune recognition and rejection and may, therefore, teach us how to actually engage effectively the immune system in the fight against tumors, thus achieving much better clinical responses and, consequently, quality of life, in our therapeutic approaches."

To make this discovery, researchers obtained a small sample of blood from breast cancer patients, and from healthy volunteers. The blood cells were then separated and induced to become dendritic cells. Researchers then used these laboratory-generated dendritic cells to induce responses from other immune system cells, namely lymphocytes. While dendritic cells from the healthy donors induced vigorous lymphocytic responses, dendritic cells from cancer patients induced mainly the activation of a specific type of lymphocyte, a regulatory lymphocyte that works as a "brake" for other types of lymphocytes.

"Understanding why the immune system does not recognize and eliminate cancer is critical to developing effective immunotherapies to fight the disease," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "Immunologists have been trying to unravel the answer to this question for decades and have realized that the problem is both on the immune system side, and because cancer cells appear to actively 'fly under the radar' avoiding immune system detection. This article offers insights into the underlying mechanisms regulating a key immune cell type, the dendritic cell, involved in initiating anti-tumor responses."

###

The Journal of Leukocyte Biology publishes peer-reviewed manuscripts on original investigations focusing on the cellular and molecular biology of leukocytes and on the origins, the developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes and other cells involved in host defense and inflammation. The Journal of Leukocyte Biology is published by the Society for Leukocyte Biology.

Rodrigo Nalio Ramos, Lilian Sally Chin, Ana Paula S. A. dos Santos, Patrcia Cruz Bergami-Santos, Fbio Laginha, and Jos Alexandre M. Barbuto. Monocyte-derived dendritic cells from breast cancer patients are biased to induce CD4+CD25+Foxp3+ regulatory T cells. J Leukoc Biol September 2012 92:673-682; doi:10.1189/jlb.0112048 ; http://www.jleukbio.org/content/92/3/673.abstract

See the rest here:
Cancer 'turns off' important immune cells, complicating experimental vaccine therapies

Biology Course at WHS Earns AP Designation

Washington High School has learned its biology course syllabus is now authorized to use the AP (Advanced Placement) designation for the 2012-13 academic year.

The AP program is a curriculum in the United States and Canada sponsored by the College Board which offers standardized courses to high school students that are generally recognized to be equivalent to undergraduate courses in college.

Participating colleges grant credit to students who obtained high enough scores on the exams to qualify.

WHS Principal Dr. Frank Wood said it also signifies the course is more rigorous than the general course offerings.

Were real pleased to learn of the AP approval, said Wood, adding that about 16 students are currently enrolled in that particular class, which includes a lab.

A letter from the AP program states that WHSs syllabus was reviewed by experienced college and university faculty, who have confirmed that it outlines how you provide a college-level learning experience for your students.

Continued here:
Biology Course at WHS Earns AP Designation

Bio-Rad Launches a Digital Biology Center to Develop Products for Research and Diagnostics Markets Based on the …

HERCULES, CA--(Marketwire -08/29/12)- Bio-Rad Laboratories, Inc. (BIO) and (BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of a Digital Biology Center to focus on the development of innovative new products based on the company's recently acquired droplet partitioning technology. The first product based on this technology, Bio-Rad's QX100 Droplet Digital PCR system that was introduced last year, applies a sample partitioning technology to polymerase chain reaction (PCR) and offers a new approach to nucleic acid quantification.

PCR is widely used to amplify and quantify nucleic acids. Droplet digital PCR offers researchers a new level of precision in the quantification of target nucleic acid molecules, providing accurate determination of copy number variation as well as the detection of rare mutation events such as those seen in certain tumors. Applications of these capabilities have the potential to provide new strategies for diagnosis of inherited disorders, cancer, and infectious disease.

"We believe the digital droplet partitioning technology, which is at the heart of our recently launched QX100 Droplet Digital PCR instrument, has potential far beyond the digital PCR market," said Annette Tumolo, Director, Digital Biology Center. "Our mission is to provide innovative products that deliver powerful, accessible solutions for digital biology and expand the reach of our digital droplet PCR technology."

About the QX100 Droplet Digital SystemThe QX100 Droplet Digital PCR system (ddPCR) provides an absolute measure of target DNA molecules with unrivaled performance in precision, accuracy, and sensitivity for quantitative PCR applications. The Droplet Digital PCR system is the third generation of PCR technology and provides a new approach to target DNA quantification. The QX100 droplet generator partitions samples into 20,000 nanoliter-sized droplets. After PCR on a thermal cycler, droplets from every sample are streamed in single file on the QX100 droplet reader. The PCR-positive and PCR-negative droplets are counted to provide absolute quantification of target DNA in digital form, detecting rare DNA target copies with unmatched sensitivity and determining copy number variation with unrivaled accuracy.

About Bio-Rad Bio-Rad Laboratories, Inc. (BIO) and (BIO.B) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 7,100 people globally and had revenues exceeding $2 billion in 2011. For more information, visit http://www.bio-rad.com.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, "believe," "expect," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the "Risk Factors" in the Company's public reports filed with the Securities and Exchange Commission, including the Company's most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.

Originally posted here:
Bio-Rad Launches a Digital Biology Center to Develop Products for Research and Diagnostics Markets Based on the ...

Tom Knight, Godfather Of Synthetic Biology, On How To Learn Something New

It was partly frustration with designing silicon chips that led Tom Knight to the study of biology. A senior research scientist at MITs Computer Science and Artificial Intelligence Laboratory, Knight started working in MITs AI Lab while he was in high school. As an MIT student and faculty member, in the 60s and 70s Knight was a co-engineer of ARPANET, a precursor of the Internet, and helped design the first commercial single-user computer workstations, eventually earning more than 30 patents for his work in computer science and electrical engineering. In the 1990s, Knight became fascinated with biology, went back to school, and set up a molecular biology lab within MITs computer science lab. There, Knight invented BioBricks--standardized DNA parts that make up a kind of free operating system for biotechnology. For his pioneering work merging concepts from engineering and biology, Knight is widely considered the godfather of the emerging science of synthetic biology. Here, this key player in the technological revolution of the last century talks about biology as this centurys defining technology, the need for scientific generalists, and the best way to learn something new.

FAST COMPANY: Internet legend has it that you started at MIT when you were 14? TOM KNIGHT: Well, that story has gotten a little overblown. I entered as a regular undergrad at the normal time. But I was a local boy--I grew up in Wakefield, Massachusetts--and I spent a lot of my high school years at MIT, taking courses in computer programming and organic chemistry, and I spent my junior and senior summers working at the artificial intelligence lab there.

So, did you study computer engineering as an undergrad? You couldnt really study computer science then--it was the bastard child of electrical engineering. This was the dawn of the artificial intelligence world at that point, and people had only been working on it for five years or so.

Did you go directly into a grad school? I took a fair amount of time off, working as a research staff member at MIT from 1969 to 1978, partly because I could get a draft deferment. During that time, I did a lot of hardware and software work having to do with operating systems, hardware maintenance, and the construction of new computers. One of the important things I helped develop was a time-sharing system called ITS that now nobody knows about, which was oriented to making users as productive as possible. Its hard to remember how bad computers were at that time--we struggled mightily to get computers that had a megabyte of core storage. Another important thing we worked on in that period of the late '60s, early '70s, was interfacing with ARPANET, which later became the NSF Net, and later the Internet. We also designed one of the first bitmap-oriented printers, which was made obsolete when laser printers came along.

Were you making money from any of this? My masters thesis when I went back to grad school in 1978 was building a computer to more efficiently run the Lisp programming language, which I worked on with my MIT colleague Richard Greenblatt. That eventually resulted in the formation of spinout companies--unfortunately two instead of one. Greenblatt and I did not see eye to eye about how to commercialize the technology, so he started Lisp Machines, and I and a number of others started our own company called Symbolics [symbolics.com was the first registered .com domain name]. Both companies were successful--Symbolics went public and resulted in several thousand machines being distributed.

How did you get into biology from computing? In the 1980s, I learned how to engineer integrated circuits, and as part of my PhD thesis, I designed one of the first silicon retinas. Looking at Moores Law, which predicts the path of technology in silicon, by 1990 I could predict that at some point--which is right about now--you wouldnt be able to do the magical shrinking act anymore [of fitting more and more transistors on an integrated circuit]. The number of atoms across the transistor becomes too small. Were now down to the 22 nanometer range, and another shrink will bring that down to 10 nanometers. Thats only about 60 atoms across. If you shrink that another factor, you have 10 or 12 atoms. The way silicon manufacturing works, you put things in place statistically, randomly. At this size, chances are youre not going to be able to get things in the right place anymore. It was clear that we needed a different way of putting atoms in the right place. There is a technology for putting atoms where you want them--its called chemistry. You design a molecule, and that has the atoms where you want them. Whats the most sophisticated kind of chemistry? Its biochemistry. I imagined that you could use bio-molecules like proteins that have the ability to self-assemble and crystallize in the range you needed.

So, you were hoping that biology could help you better engineer silicon chips? Yes, that was part of what got me interested in biology. Something else that really changed my thinking was a proposal by a physicist-turned-biologist names Harold Morowitz called A Complete Understanding of Life. How can you not like something like that! His basic proposal was that we have all this advanced technology--if we put our minds to it and applied all this technology, we could actually understand how simple organisms work. My general bias toward biology at that point was, Oh my god, its so complicated, well never figure out whats going on--in contrast to something like computers where you can understand everything. It was really quite amazing to see somebody proposing what Id assumed was impossible. I got quite intrigued by the idea that I could go and do something with biology.

But you were no expert on biology--how did you get up to speed? Starting in 1990 or so, I started seriously looking at classical biology books, with a strong concentration on simple organisms. I started taking the graduate core courses in biology at MIT and basically became a student. It was challenging but very effective for educating myself. In 1995, along with one of my students, I took the sophomore undergraduate intro to molecular biology class--that was fun, learning how to pipette and work in the lab.

Do you have any study tips for other people who are trying to learn a new subject? I like to read books, three or four at a time. I rarely read books all the way through. Ill get a few books on a subject--you want single-author books, someone with a well-defined point of view--and read a section, and then switch to a different book and read about the same thing. I keep switching back and forth--its a great technique because you get to look at the same subject from many peoples perspective. That turns out to be actually really useful.

How did your outsider's perspective as a computer engineer inform your approach to biology? After setting up a molecular biology lab in the computer science department at MIT, it became clear to me that I didnt want to do plumbing in the way biology had been doing it for two decades. My basic realization was that every time I wanted to do one experiment, it was actually two experiments: 1. the experiment I wanted to do, and 2. building the piece of DNA I wanted. The second experiment was not that intellectually interesting, and it wasnt publishable. It just became annoying. The question was, how do you get rid of that?

The rest is here:
Tom Knight, Godfather Of Synthetic Biology, On How To Learn Something New

pH-sensitive liposomal cisplatin improves peritoneal carcinomatosis treatment without side-effects

Public release date: 27-Aug-2012 [ | E-mail | Share ]

Contact: Andrea Teixeira Carvalho atcteixeira@gmail.com Society for Experimental Biology and Medicine

Scientists at the Oswaldo Cruz Foundation and Federal University of Minas Gerais, led by Dr. Andra Teixeira-Carvalho and Dr. Mnica Cristina de Oliveira, have developed and characterized a circulating and pH-sensitive liposome containing cisplatin (SpHL-CDDP) aiming to promote the release of cisplatin near the tumor as well as decreasing toxicity. The development of analog drugs and new formulations are current strategies for increasing the effectiveness and safety of cisplatin as an anti-peritoneal carcinomatosis drug. The results, which appear in the August 2012 issue of Experimental Biology and Medicine demonstrate that the treatment of initial or disseminated Ehrlich ascitic tumor-bearing Swiss mice with SpHL-CDDP improved the antitumor efficacy and decreased renal and bone marrow toxicity of cisplatin-based therapy.

"Peritoneal carcinomatosis is a serious concern in the treatment of abdominal tumors such as hepatic, gastric and gynecological tumors", says Dr. Oliveira. "The strategy of local chemotherapy is interesting due to the possibility to increase the therapeutic efficacy while minimizing systemic side-effects. SpHL-CDDP treatment was able to reduce cancer cell proliferation and increase survival, in the animal model, with no known toxicity clinical signs found in the free CDDP treatment." says Dr. Maroni.

These results open the possibility of future use of SpHL-CDDP in chemotherapy of peritoneal carcinomatosis. "New studies are underway in our research group to investigate the signaling pathways of cell death as well as use of high doses of SpHL-CDDP for the treatment of peritoneal carcinomatosis", says Dr. Teixeira-Carvalho.

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said " This very interesting study has utilized a new pH-sensitive circulating liposome containing cisplatin formulation which decreased cancer proliferation and drug toxicity in a mouse model. This provides the basis for further translational testing of this formulation leading to clinical trials aimed at more effective treatment of abdominal tumors".

###

Experimental Biology and Medicine is a journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. The journal was first established in 1903.

Experimental Biology and Medicine is the journal of the Society of Experimental Biology and Medicine. To learn about the benefits of society membership visit http://www.sebm.org. If you are interested in publishing in the journal please visit http://ebm.rsmjournals.com .

The rest is here:
pH-sensitive liposomal cisplatin improves peritoneal carcinomatosis treatment without side-effects

Lessons From Bangladesh

Glenn Hicks of the Institute for Integrative Genome Biology teaches a workshop at the University of Dhaka, Bangladesh.

PHOTO CREDIT: G. HICKS, UC RIVERSIDE.

RIVERSIDE, Calif. Before he left for Bangladesh to conduct a workshop this summer, Glenn Hicks of the University of California, Riverside did not quite know what to expect. What he knew was that he would be leading a workshop, called Workshop on Genomics and Proteomics, from July 16 through July 24 at the University of Dhaka, the premier public university in Bangladesh. What his brief visit to that countrys capital taught him, though, was that education is critical for all of our futures and that with patience education could help overcome even great cultural and economic differences.

Aimed at providing an overview of genomics and proteomics, the workshop, the first of its kind that UC Riverside has offered in Bangladesh, was funded by the World Bank and hosted by the University of Dhakas Botany Department.

I learned, too, that many of the research projects in the department were biotechnology-oriented towards solving problems that are important for, and in some cases unique to, Bangladesh projects like plant virus and fungal disease resistance, bioremediation, and production of biomass for feeds and fertilizers, he added.

Faculty and students at the University of Dhaka, Bangladesh, recently attended a workshop presented by UC Riversides Glenn Hicks.

PHOTO CREDIT: G. HICKS, UC RIVERSIDE.

Hicks found that although the University of Dhaka is a large university, its infrastructure is limited in terms of opportunities for the most up-to-date research and postgraduate studies utilizing advanced methods and technologies. For example, the laboratories he toured had basic equipment for molecular biology research, but access to advanced instrumentation was limited. Still, the students and faculty were eager to learn, he found, and sincere in their desire for more high-quality research.

They have a strong hunger for more contemporary knowledge and hands-on scientific training, Hicks said. Many of the faculty are smart and forward looking. They are acutely aware of the need to target new areas for learning. While some of the highest-technology equipment is not available to them as yet, procuring knowledge is what matters as a start. From there, meaningful projects and focused infrastructure can follow. This was noted by the vice chancellor of the University of Dhaka, Professor Siddique, whom I was able to meet. He was very supportive of future interactions with UCR.

The trip to Bangladesh, his first, was an opportunity for Hicks to make a significant contribution beyond the UCR campus. An early difference he made there was getting the workshop participants to ask questions in the ten lectures he presented.

View post:
Lessons From Bangladesh

UCDs' Simon Chan made plant breakthroughs

Simon Chan, shown in his UC Davis plant biology lab, led the discovery of how to breed plants with genes from only one parent. (Steve Yeater/Associated Press)

Chan had been suffering from primary sclerosing cholangitis, an autoimmune disorder, and developed complications while awaiting a liver transplant.

"Simon was an incredible scientist, superb mentor and a great friend," said James Hildreth, dean of the College of Biological Sciences at UCD. "His brilliant work could fundamentally change how new crop plants are generated and may shed light on how new plant species are formed."

Professor Bill Lucas, chair of the Department of Plant Biology, described Chan as "one of a kind."

"His enthusiasm for his science was contagious and his passion for teaching and mentoring his students served as a true role model for us all. Words cannot express our deep sorrow at losing such a talented and wonderful human being," Lucas said.

Working with the model plant Arabidopsis, Chan's laboratory discovered a way to breed plants with genes from only one parent, making it possible to "breed true" without generations of inbreeding.

In June 2011, Chan was one of two UC Davis scientists selected for the first-ever class of HHMI-GBMF Investigators, funded jointly by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation to support promising research in plant sciences. (The other awardee was Jorge Dubcovsky, professor of plant

Chan planned to use the HHMI-GBMF award to expand his work to crop plants such as tomatoes and Chinese cabbage.

Chan was also working with plant breeders in Colombia, Tanzania and Kenya to find new ways to breed bananas, plantain and cassava, staple foods for millions of the world's poorest people. That project was supported by a grant from the NSF-BREAD (Basic Research to Enable Agricultural Development) program, a joint initiative of the Bill & Melinda Gates Foundation and the National Science Foundation.

Chan was born in 1974 in Auckland, New Zealand, and earned his bachelor's degree in biochemistry from the University of Auckland in 1996. From there he went to UCSF, where he worked with Professor Elizabeth Blackburn, winner of the 2009 Nobel Prize in physiology or medicine, and was awarded his doctoral degree in cell biology in 2006.

Follow this link:
UCDs' Simon Chan made plant breakthroughs

Synthetic Biology Turns Cells Into Chemists Producing Treatments For Diabetes And Cancer — And Easing Journeys To Mars

Imagine a diabetic with specially engineered cells that detect the rise and fall of his or her blood sugar and administer insulin if needed. Imagine cancer patients intentionally infected with a "smart virus" that can determine if cells are cancerous and then destroy the dangerous cell from the inside. And imagine cells engineered to excrete biofuels or pharmaceutical products.

These are the visions of synthetic biology. A relatively new breed of researchers, synthetic biologists view the future through a lens in which specially designed DNA sequences, proteins and cells do the work of creating compounds, elements and biological materials that help us treat diseases, produce new kinds of medicines and even establish colonies on other planets.

"The big breakthrough 100 years ago was organic chemistry, when people figured out how to make synthetic materials," says Harvard University biologist Pamela Silver. But "a cell is probably an even better chemist."

The concepts behind synthetic biology have since at the least the 1970s, when scientists inserted the genes to make human insulin into E. coli bacteria, but the outcomes of experiments were notably hit and miss. That's changing quickly.

"Now we're coming to a point where, when I say this part does something, other designers can trust it," said Adam Arkin, a professor of engineering and the director of the University of California at Berkeley's synthetic biology institute.

Follow us

One project Silver and her colleagues at Harvard are working on is building human and other mammalian cells that can record and remember past events and also be able to "count" forward in time. Such clocked cells would be useful as sensors and could also be part of a new wave of intelligent therapeutics, remembering how a patient's body reacted to previous treatments.

Another project, backed by the U.S. Department of Energy, is a genetically engineered bacteria named Shewanella.Silver and her team are trying to rejigger the bacteria's photosynthetic pathways so it will accept electricity instead of light as an energy source, an advance that would allow biofuel-excreting microorganisms to be plugged into the grid. The Harvard team is also trying to engineer Shewanella to generate fuel that's similar to diesel fuel or gasoline and which requires no additional chemical processing after being pumped out of the bacteria-filled tank.

"It's a very 'blue sky'-type project," Silver says, meaning that Shewanella's success is uncertain.

Synthetic biology's arrival on the scene coincided with the first International Genetically Engineered Machine competition in 2004, in which five teams worked on building their own biological systems. In that initial competition, a team from the University of Texas at Austin created a bacterial photographic "film" using color-changing bacteria that responded to light input. One image captured on this film was two lines of text: "Hello World."

More:
Synthetic Biology Turns Cells Into Chemists Producing Treatments For Diabetes And Cancer -- And Easing Journeys To Mars